Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding;Antirheumatische therapie und reproduktion. Einfluss auf fertilität, schwangerschaft und stillzeit

Zeitschrift fur Rheumatologie

Volumn 65, Issue 3, 2006, Pages 217-224

  Ostensen M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Breast feeding; Cyclophosphamide; Disease modifying drugs; Fertility; Non steroid anti inflammatory drugs; Pregnancy; TNF alpha antagonists

Indexed keywords

ADALIMUMAB; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CHLOROQUINE; COLESTYRAMINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOSTATIC AGENT; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FENOPROFEN; HYDROXYCHLOROQUINE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INFLIXIMAB; ISOXICAM; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PREDNISONE; SALAZOSULFAPYRIDINE; TERATOGENIC AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG;

BIRTH CONTROL; BREAST FEEDING; DRUG SAFETY; FERTILITY; HUMAN; INFERTILITY; LACTATION; PREGNANCY; REPRODUCTION; REVIEW; RHEUMATOID ARTHRITIS; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANTIRHEUMATIC AGENTS; BREAST FEEDING; CYCLOPHOSPHAMIDE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; FERTILITY; GLUCOSAMINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; RHEUMATIC DISEASES; SULFASALAZINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745127676     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-006-0052-5     Document Type: Review

References (29)

1. Alano MA, Ngougmna E, Ostrea EM Jr, Konduri GG (2001) Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 107: 519-513
2. Bar-Oz B, Hackman R, Einarson T, Koren G (2001) Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 71: 1051-1055
3. Borden MB, Parke AL (2001) Antimalarial drugs in systemic lupus erythematosus. Use in pregnancy. Drug safety 24: 1055-1063
4. Boumpas DT, Howard AA, Vaughan EM et al. (1993) Risk of sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cylcophosphamide therapy. Ann Intern Med 119: 366-369
5. Chakravarty EF, Sanchez-Yamamoto D, Bush TM (2003) The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcome. J Rheumatol 30: 241-246
6. Cimaz R, Meregalli E, Biggioggero M et al. (2004) Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. Toxicol Lett 149: 155-162
7. Clovis A, Silva A, Hallak J et al. (2002) Gonadal function in male adolescents and young males with juvenile onset systemic lupus erythematosus. J Rheumatol 29: 2000-2005
8. Committee on Drugs. American Academy of pediatrics (2001)The transfer of drugs and other chemicals into human milk. Pediatrics 108: 776-789
9. Costedoat-Chalumeau N, Amoura Z et al. (2003) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48: 3207-3211
10. Czeizel AE, Rockenbauer M (1997) Population-based case-control study of teratogenic potential of corticosteroids. Teratology 56: 335-340
11. Feldkamp M, Carey JC (1993) Clinical teratology counseling and consultation case report: low dose methotrexate exposure in early weeks of pregnancy. Teratology 47: 533-539
12. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Eng J Med 343: 1608-1614
13. Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA (1989) The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol 160: 1525-1531
14. Katz JA, Antoni C, Keenan GF et al. (2004) Outcome of pregnancy in women receiving Infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 99: 2385-2392
15. Mendonca LLF, Khamashta MA, Nelson-Piercy C, Hughes GRV (2000) Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology 39: 880-882
16. Mirkes PE (1985) Cyclophosphamide teratogenesis. A review. Teratogen Carcinogen Mutagen 5: 75-88
17. Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW (1981) Pregnancy in inflammatory bowel disease: effect of sulphasalazine and corticosteroids on fetal outcome. Gastroenterology 80: 72-76
18. Norgard B, Czeizel AE, Rockenbauer M et al. (2001) Population based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 15: 483-486
19. O'Morain C, Smethurst P, Dore CJ et al. (1984) Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 25: 1078-1084
20. Østensen M, Østensen H (1996) Safety of nonsteroidal antiinflammatory drugs in pregnant patients with rheumatic disease. J Rheumatol 23: 1045-1049
21. Østensen M, Hartmann H, Salvesen K (2000) Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 27: 1872-1875
22. Østensen M, Khamashta M, Lockshin M et al. (2006) Antirheumatic drugs and reproduction. Arthritis Res Ther (in press)
23. Park-Wyllie L, Mazzotta P, Pastuszak A et al. (2000) Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 62: 385-392
24. Pergola PE, Kancharla A, Riley DJ (2001) Kidney transplantation during the first trimenon of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. Transplantation 71: 994-997
25. Polifka JE, Friedman JM (2002)Teratogen update: Azathioprine and 6-Mercaptopurine. Teratology 65: 240-261
26. Ramsey-Goldman R, Mientus JM, Kutzer JE et al. (1993) Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 20: 1152-1157
27. Slater CA, Liang MH, McCune JW et al. (1999) Preserving ovarian function in patients receiving cyclophosphamide. Lupus 8: 3-10
28. Spigset O, Hägg S (2000) Analgesics and breast-feeding. Safety considerations. Paediatric Drugs 2: 223-238
29. Vermillion ST, Scardo JA, Lashus AG, Wiles HB (1997) The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 177: 256-261